Thomas Jarboe
Pulmonary Disease · Lexington, KYNPI 1679599682
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 141 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by Boehringer Ingelheim at 26.4% of the total. Reporting peaked in 2021 at $1,067 and has fallen 93.0% since, to $75 in 2023. That places this record below the midpoint for pulmonary disease clinicians in KY, where the typical reported total is $4,124.
Across 141 payments — averaging $18.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$684
- GSK$457
- Actelion Pharmaceuticals US, Inc.$292
- Sanofi$280
- Grifols USA, LLC$243
- AstraZeneca$206
- plus $424 from 11 others
What the payments were for
- Food & beverage$2,585100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 38 | $684 |
| GSK | 26 | $457 |
| Actelion Pharmaceuticals US, Inc. | 14 | $292 |
| Sanofi | 15 | $280 |
| Grifols USA, LLC | 14 | $243 |
| AstraZeneca | 13 | $206 |
| Mylan Specialty L.p. | 5 | $100 |
| Mallinckrodt Hospital Products Inc. | 3 | $69 |
| Sunovion Pharmaceuticals Inc. | 3 | $49 |
| Insmed, Inc. | 2 | $42 |
| Genentech USA, Inc. | 2 | $35 |
| Medtronic | 1 | $30 |
| Mallinckrodt Enterprises LLC | 1 | $25 |
| Jazz Pharmaceuticals Inc. | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| Circassia Inc. | 1 | $16 |
| Merck | 1 | $14 |
How this compares
$2,585 in reported general payments places this provider in the 40th percentile of 226 pulmonary disease providers in Kentucky.
Other pulmonary disease in Lexington
- Dennis DohertyLexington$103K
- Ashish MaskeyLexington$94K
- Girish NairLexington$86K
- John ThompsonLexington$77K
- Anthony GerberLexington$20K
- Eliseo Colon-CarrerasLexington$17K
- Christopher MeenachLexington$15K
- Theresa CaseLexington$14K
- John McConnellLouisville$864K
- Erica GregonisRichmond$390K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.